Is this the holy grail of cancer tests?

Trevor Lockett is the CEO and Managing Director of Rhythm Biosciences. Rhythm’s technology came out of the CSIRO as did Trevor Lockett and they are developing a blood test for colorectal cancer. Alan Kohler gave Trevor a call to see how it’s all progressing.

Become a TCI Community Member Now

Stay up to date and make better informed decisions.
Get access to all this exclusive content and so much more every week!

  • $1 for the first month
  • $25/month membership
  • Cancel anytime, no lock in contract
  • Access to Private Facebook group
  • Smartphone App (coming soon)